Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 12 04:00PM ET
30.39
Dollar change
-0.39
Percentage change
-1.28
%
CategoryGlobal or ExUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsGlobal Return% 1Y9.19% Shs Outstand Perf Week-0.56%
SponsorFranklin Templeton ETF Type Tagsequity Return% 3Y-14.28% Total Holdings67 Perf Month-1.33%
Fund Family Bond Type Tagshealthcare Return% 5Y- AUM13.84M Perf Quarter-8.07%
Index- Average Maturity Tagsgenomics Return% 10Y NAV% Perf Half Y-5.81%
Index Weighting Commodity Type Tags- Return% SI NAV/sh Perf Year7.80%
Active/Passive Quant Type Tags- Flows% 1M28.76% 52W Range28.07 - 33.98 Perf YTD-0.27%
Dividend TTM- ESG Type Tags- Flows% 3M51.48% 52W High-10.56% Beta1.06
Dividend Ex-DateDec 30, 2021 Dividend Type Sector/Theme Flows% YTD30.09% 52W Low8.26% ATR (14)0.38
Expense0.50% Structure Type Region Flows% 1Y RSI (14)46.53 Volatility0.74% 0.93%
Option/ShortYes / No Growth/Value Dev/Emerg Flows% 3Y Rel Volume0.07 Prev Close30.78
Inverse/Leveraged Market Cap Currency Flows% 5Y Avg Volume3.66K Price30.39
SMA200.49% SMA50-1.72% SMA200-4.47% Trades Volume255 Change-1.28%
Jul-16-21 11:19AM
Jan-14-21 09:15AM
Oct-05-20 08:00AM
Franklin Genomic Advancements ETF seeks capital appreciation. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.